Ignite Creation Date:
2025-12-24 @ 1:57 PM
Ignite Modification Date:
2026-01-02 @ 1:27 PM
Study NCT ID:
NCT00517595
Status:
COMPLETED
Last Update Posted:
2012-03-12
First Post:
2007-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC
Sponsor:
Accelerated Community Oncology Research Network
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ALJBNSCLC0602
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None